News News

March 6, 2020 Industry, academia pivot: Pipeline of COVID-19 vaccine and therapeutic candidates doubles

A list of biopharma companies and nonprofit entities, including academia, working feverishly to find a vaccine or…

Opt
March 4, 2020 Sirnaomics to Present at 5th Annual Oligonucleotide & Precision Therapeutics Congress

Sirnaomics Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and…

February 19, 2020 Hunt for New Coronavirus Treatments Includes Gene-Silencing and Monoclonal Antibodies

Viral infections can be very hard to treat. Just ask anyone who has a bad case of…

February 10, 2020 Sirnaomics’ siRNA Therapeutic Candidate, STP705, Granted Orphan Drug Designation By US FDA for Treatment of Hepatocellular Carcinoma

Sirnaomics, Inc., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the…

January 28, 2020 Sirnaomics to develop RNAi-based therapeutics for 2019-nCoV infections

The outbreak of 2019-nCov infection, which causes respiratory illness, was first detected in Wuhan City, China, and…

Coronavirus 1
January 27, 2020 Coronavirus: AbbVie and Sirnaomics drug candidates explored for Covid-19

Amid the search for cure and treatments, China is testing the use of AbbVie’s HIV drugs to…

1 3 4 5 6 7 12